These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9831170)

  • 1. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
    Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
    Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
    Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
    Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
    Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
    Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
    Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
    Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A; Ikeda Y
    Rinsho Byori; 1998 May; 46(5):430-4. PubMed ID: 9627493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction by the peptide which mimics the activity of thrombopoietin.
    Kimura T; Kaburaki H; Tsujino T; Watanabe Y; Kato H
    Biochem Mol Biol Int; 1998 May; 44(6):1203-9. PubMed ID: 9623775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
    Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
    Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin signal transduction: studies from cell lines and primary cells.
    Drachman JG; Rojnuckarin P; Kaushansky K
    Methods; 1999 Mar; 17(3):238-49. PubMed ID: 10080909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
    Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
    Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
    Ooi J; Tojo A; Asano S; Sato Y; Oka Y
    Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tec protein-tyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway.
    Yamashita Y; Miyazato A; Shimizu R; Komatsu N; Miura Y; Ozawa K; Mano H
    Exp Hematol; 1997 Mar; 25(3):211-6. PubMed ID: 9091296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.